Rizatriptan Benzoate Tablet, Orally Disintegrating
Product Images NDC 33342-094

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 33342-094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Rizatriptan Figure 1)

FDA Label Image

Figure-2 (Rizatriptan Figure 2)

FDA Label Image

Figure-3 (Rizatriptan Figure 3)

This is a chart showing estimated probability of response for placebo and two types of Rizatriptan Benzoate OD Tablets (5mg and 10mg) over the course of 15 hours post-dose. The x-axis represents the hours post-dose and the y-axis shows the probability of response, ranging from 0% to 100%.*

FDA Label Image

Figure-4 (Rizatriptan Figure 4)

FDA Label Image

Rizatriptan Figure 5

The text seems to be a graph or a chart showing the percentage of something, possibly related to Rizatriptan Benzoate orally disintegrating tablets and a placebo, over 20 hours. The exact details of the graph/chart are not clear due to errors.*

FDA Label Image

Rizatriptan Odt Usp 10mg 1x3s

This is a description of Rizatriptan Benzoate Orally Disintegrating Tablets, with a code number and the manufacturer's details. The tablets come in blister packs of three and should be dispensed with a patient information leaflet. The drug contains Phenylalanine and Aspartame, and each 10mg tablet contains 14.53mg Phenylketonurics. The adult dosage should be based on the prescribing information and the tablets should be stored at a temperature between 20°C to 25°C.*

FDA Label Image

Rizatriptan Odt Usp 10mg 2x6ss

This is a prescription drug information for Rizatriptan Benzoate Orally Disintegrating Tablets, USP. It contains instructions for use, dosage administered, and store temperature range. The has missed out on specific content in the text, but the essential details are still understandable.*

FDA Label Image

Rizatriptan Odt Usp 10mg 3x3s

This is a description of a drug package for Rizatriptan Benzoate Orally Disintegrating Tablets. It contains information such as dosage, storage instructions and manufacturing details. The package includes 9 tablets in blister packs and comes with a patient information leaflet. The drug is manufactured by Macleods Pharma USA, Inc. and Madieods Pharmaceuticals Ltd. in India. The tablets contain phenylalanine and aspartame. The text may not be fully readable due to errors.*

FDA Label Image

Rizatriptan Odt Usp 10mg 3x6s

The text seems to be describing a drug called Rizatriptan Benzoate Orally Disintegrating Tablets. It provides the NDC number, packaging information, and dosage instructions for adults. It also includes an instruction for opening blister packs. The manufacturer is mentioned as Macleods Pharmaceuticals located in India. The text may be useful for pharmacists dispensing the drug to patients.*

FDA Label Image

Rizatriptan Odt Usp 10mg 6x3s

This is a drug information guide for Rizatriptan Benzoate Orally Disintegrating Tablets, USP. It provides information on the product, dosage, and storage instructions. The tablets come in a blister pack of 18 tablets, each containing 10 mg of rizatriptan benzoate USP. It is manufactured by Macleods Pharma USA and manufactured in India. The guide also advises pharmacists to include the patientinformation leaflet when dispensing the product. The guide warns that the product contains phenylalanine, which is harmful to people with phenylketonuria. The tablets should be stored at 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F).*

FDA Label Image

Rizatriptan Odt Usp 5mg 1x3s

This is a description of Rizatriptan Benzoate Orally Disintegrating Tablets manufactured by Macleods Pharma USA, Inc. It provides the NDC code, dosage information, and instructions for opening the blister pack. It also cautions about the product's storage temperature and notes that it contains phenylalanine, which is a component of aspartame. The text includes errors and is difficult to read.*

FDA Label Image

Rizatriptan Odt Usp 5mg 2x6ss

This is a pharmaceutical label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP. The label tells the pharmacist to dispense the patient information leaflet with the drug product. It also contains information regarding dosage and storage of the medication. The label is produced by Macieods Prarma USA, Inc, with an address and contact details provided. The other text seems to be gibberish.*

FDA Label Image

Rizatriptan Odt Usp 5mg 3x3s

The text contains information about a medication called Rizatriptan Benzoate, which is available in orally disintegrating tablets. It comes in a pack with 3 unit-dose tablets, and each tablet contains 5 mg of the active ingredient. The medication is intended for adult use only, and the dosage should be determined by a healthcare professional. The medication should be stored at a temperature between 20° to 25°C. The text also includes the drug's National Drug Code (NDC) number, the manufacturer's name, and the location where it is manufactured.*

FDA Label Image

Rizatriptan Odt Usp 5mg 3x6s

FDA Label Image

Rizatriptan Odt Usp 5mg 6x3s

Rizatriptan Benzoate Orally Disintegrating Tablets, USP is a drug product manufactured by Macleods Pharma USA, Inc. It is dispensed to the patient as 18 tablets in a blister pack, each tablet containing 5 mg of rizatriptan per 5 mg orally disintegrating tablets. It is a prescription drug and the usual adult dosage should be as per the prescribing information. Storage at 20° to 25°C and excursions permitted to 15° to 30°C in a controlled room temperature as per USP guidelines is recommended. The text also contains instructions for dispensing by pharmacists, which can be referred to for more information.*

FDA Label Image

Structure (Rizatriptan Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.